Angiogenesis in Myocardial Ischemia: An Organized Review
PharmaTutor (November- 2013)
Received On: 18/10/2013; Accepted On: 03/11/2013; Published On: 25/11/2013
Authors: Jalaram H Thakkar*, Ashiyana A Mansuri, Chirag Patel, Girish K Jani,
Department of Pharmacology,
SSR College of Pharmacy, Silvassa, Gujarat
*jay_143143@yahoo.com
ABSTRACT:The term Angiogenesis was coined by DR. John Hunter, a British surgeon in 1787. Later professor Judah Folkman gave the idea that growth of tumor depends on their blood supply and a new began research in this new field of therapeutics called ANGIOGENESIS. Then, the identification of angiogenic growth factors, Vascular Endothelial Growth Factor (VEGF) and Fibroblast Growth Factor (FGF) fueled interest in using these factors in inducing therapeutic angiogenesis.[1] Initially angiogenesis was implicated only in few diseases like cancer, psoriases and arthritis. But, in recent years, it has been evident through a deep research that even excessive, insufficient and abnormal angiogenesis contribute to the pathogenesis of many disorders. Angiogenesis is regulated by a balance between pro- and anti- angiogenic factors. Research shows that angiogenesis and anti angiogenesis has given promising results in treatment of diseases like AIDS, atherosclerosis, ischemic heart disease and Alzheimer’s. In twenty first century, application of angiogenesis in therapeutics may have an impact on disorders similar to that which the discovery of antibiotics had in twentieth century.
How to cite this article: JH Thakkar, AA Mansuri, C Patel, GK Jani, Angiogenesis in Myocardial Ischemia: An Organized Review, PharmaTutor, 2013, 1(1), 65-74
REFERENCES:
1. The angiogenesis foundation, Understanding angiogenesis (document on internet). angio.org.in/ua.php
2. rndsystem.com – Angiogenesis and Vasculogenesis.
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat med1995; 1:27-31.
4. Papetti M, Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 2002;282:C947-70
5. Ausprunk DH, Folkman J. Migration and proliferation of endothelial cells in performed and newly performed blood vessels during tumor angiogenesis. Microvasc Res 1977;14:53-65
6. Bischoff J. Cell adhesion and angiogenesis. J Clin Invest 1997;100:S37-9
7. Himadri Roy, Shalini Bhardwaj, Seppo Yla¨-Herttuala “Biology of vascular endothelial growth factors” FEBS Letters;2006; 580; 2879–87
8. Jade Homsi, , Adil I. Daud. Spectrum of Activity and Mechanism of Action of VEGF/PDGF Inhibitors. Journal of the Moffitt Cancer Center. 2007; 14(3):285-295.
9. Peter J. Polverini. Angiogenesis in Health and Disease Insights into Basic Mechanisms and Therapeutic Opportunities. Journal of Dental Education 2002; 66(8):962-976.
10. Sandra Liekens, Erik De Clercq, Johan Neyts. Angiogenesis: regulators and clinical applications. Biochemical Pharmacology 2001;61;253–270
11. Unger EF, Shou M, Sheffield CD et al. Extracardiac to coronary anastomoses supports regional left ventricular function in dogs. Am J Physiol 1993; 264 (5 Pt 2): H 1567-74.
12. Unger EF, Banai S, Shou M et al. A model to assess interventions to improve collateral blood flow: Continuous administration of agents into the left coronary artery in dogs. Cardiovasc Res 1993; 27 (5): 785-91.
13. Battler A, Scheinowitz M, Bor a et al. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infracted swine myocardium. J Am Coll Cardiol 1993; 22 (7): 2001-06.
14. Gregg L. Semenza. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. TRENDS in Molecular Medicine 2001; 7 (8):345-351.
15. Schofield and Ratcliffe. Oxygen sensing by HIF hydroxylases. Nature Reviews Molecular Cell Biology 2004; 5: 343-354.
16. Sandri, M., et al. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes results of three randomized studies. Circulation 2005;111;3391–3399
17. Napoleone ferrara, Robert S. kerbel. Angiogenesis as a therapeutic target. Nature 2005; 438; 967-974.
18. Saul Benedict Freedman, Jeffrey M. Isner. Therapeutic Angiogenesis for Ischemic Cardiovascular Disease. J Mol Cell Cardiol 2001; 33,;379–393
19. Hilal Al Sabti. Therapeutic angiogenesis in cardiovascular disease. Journal of Cardiothoracic Surgery 2007;2;49-56
20. Gibaldi M: Regulating angiogenesis: A new therapeutic strategy. J Clin Pharma 1998; 38; 898-903.
21. Nagel T, Resnick N, Atkinson WJ, Dewey CF Jr, Gimbrone MA Jr: Shear stress selectively upregulate intracellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest 1994; 94; 885-891.
22. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D: Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 1990; 172;1535-45
23. R. Tabibiazar and S. G. Rockson. Angiogenesis and the ischemic heart. European Heart Journal 2001; 22;903–918
24. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99; 2625-34.
25. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T: Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis. Circulation 1999;99;1141-6
26. Isner JM. Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscle. J Clin Invest. 2000; 106: 615–619.
27. Isner JM, Asahara T. Angiogenesis and Vasculogenesis as therapeutic strategies for postnatal vascularization J Clin Invest. 1999; 103: 1231–1236.
28. Michio Kawasuji. Therapeutic Angiogenesis for Ischemic Heart Disease. Ann Thorac Cardiovasc Surgi 2002; 8 (2); 59-61.
29. Simons M, Bonnow RO, Chronos NA, et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 2000; 102: e73–86.
30. Post MJ, Laham R, Sellke FW, Simons M. Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc Res 2001; 49: 522–31.
31. Yin-Shan Ng and Patricia A D’Amore. Therapeutic angiogenesis for cardiovascular disease. Curr Control Trials Cardiovasc Med 2001; 2; 278-285.
32. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub MH: Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 2001; 104; I207-12.
.png)
